TR199701605A2 - Sülfonamid-substitüe edilmis bilesikler - Google Patents

Sülfonamid-substitüe edilmis bilesikler

Info

Publication number
TR199701605A2
TR199701605A2 TR97/01605A TR9701605A TR199701605A2 TR 199701605 A2 TR199701605 A2 TR 199701605A2 TR 97/01605 A TR97/01605 A TR 97/01605A TR 9701605 A TR9701605 A TR 9701605A TR 199701605 A2 TR199701605 A2 TR 199701605A2
Authority
TR
Turkey
Prior art keywords
lfonamid
ikler
edilmi
substit
bile
Prior art date
Application number
TR97/01605A
Other languages
English (en)
Inventor
Brendel Joachim
Jochen Lang Hans
Gerlach Uwe
Weidmann Klaus
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996152213 external-priority patent/DE19652213A1/de
Priority claimed from DE1997130326 external-priority patent/DE19730326A1/de
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of TR199701605A2 publication Critical patent/TR199701605A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/16—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Formül I'e sahip bilesikler substitüentlerin istemlerde belirtilen anlamlari ile,kalp-dolasim bozukluklarinin,özellikle de aritmilerin tedavisi ve profilaksisi,mide-bagirsak bölgesindeki ülserlerin veya diare ile giden hastaliklarin tedavisi için ilaçlarin üretimine yönelik mükemmel etkenlige sahip maddelerden
TR97/01605A 1996-12-16 1997-12-12 Sülfonamid-substitüe edilmis bilesikler TR199701605A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996152213 DE19652213A1 (de) 1996-12-16 1996-12-16 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1997130326 DE19730326A1 (de) 1997-07-15 1997-07-15 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
TR199701605A2 true TR199701605A2 (tr) 1998-07-21

Family

ID=26032247

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01605A TR199701605A2 (tr) 1996-12-16 1997-12-12 Sülfonamid-substitüe edilmis bilesikler

Country Status (24)

Country Link
US (1) US5856338A (tr)
EP (1) EP0847996B1 (tr)
JP (1) JP4317601B2 (tr)
KR (1) KR19980064151A (tr)
CN (1) CN1185435A (tr)
AT (1) ATE234821T1 (tr)
AU (1) AU725699B2 (tr)
BR (1) BR9706142A (tr)
CA (1) CA2224885A1 (tr)
CZ (1) CZ403997A3 (tr)
DE (1) DE59709560D1 (tr)
DK (1) DK0847996T3 (tr)
ES (1) ES2195071T3 (tr)
HR (1) HRP970684A2 (tr)
HU (1) HUP9702475A3 (tr)
ID (1) ID19152A (tr)
IL (1) IL122576A0 (tr)
NO (1) NO975887L (tr)
NZ (1) NZ329200A (tr)
PL (1) PL323809A1 (tr)
PT (1) PT847996E (tr)
SI (1) SI0847996T1 (tr)
SK (1) SK171797A3 (tr)
TR (1) TR199701605A2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
WO2001079525A2 (en) 2000-04-14 2001-10-25 Vanderbilt University Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
CN113402476B (zh) * 2021-06-21 2022-04-19 广东湛江海洋医药研究院 一种亚胺噁嗪衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
WO1994004521A1 (en) * 1992-08-17 1994-03-03 Chugai Seiyaku Kabushiki Kaisha Benzopyran and benzoxazine derivatives
AU711986B2 (en) * 1996-05-15 1999-10-28 Hoechst Aktiengesellschaft Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them

Also Published As

Publication number Publication date
MX9710126A (es) 1998-07-31
DK0847996T3 (da) 2003-06-30
EP0847996A1 (de) 1998-06-17
HRP970684A2 (en) 1998-10-31
NZ329200A (en) 1999-05-28
EP0847996B1 (de) 2003-03-19
JPH10182610A (ja) 1998-07-07
NO975887D0 (no) 1997-12-15
BR9706142A (pt) 1999-05-18
NO975887L (no) 1998-06-17
SK171797A3 (en) 1998-07-08
HUP9702475A2 (hu) 1999-06-28
JP4317601B2 (ja) 2009-08-19
CA2224885A1 (en) 1998-06-16
HU9702475D0 (en) 1998-03-02
IL122576A0 (en) 1998-06-15
PT847996E (pt) 2003-07-31
ES2195071T3 (es) 2003-12-01
KR19980064151A (ko) 1998-10-07
PL323809A1 (en) 1998-06-22
SI0847996T1 (en) 2003-08-31
CN1185435A (zh) 1998-06-24
US5856338A (en) 1999-01-05
CZ403997A3 (cs) 1998-07-15
HUP9702475A3 (en) 2000-01-28
AU4837397A (en) 1998-06-18
DE59709560D1 (de) 2003-04-24
ATE234821T1 (de) 2003-04-15
AU725699B2 (en) 2000-10-19
ID19152A (id) 1998-06-18

Similar Documents

Publication Publication Date Title
BG105270A (en) Tetrahydropyridoethers
DE69429524T2 (de) Aminocyclohexylester und ihre anwendung
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE400577T1 (de) Anellierte dihydropyrane
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
IT1285770B1 (it) Composti corticoidei
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
AU612172B2 (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
ATE386742T1 (de) Imidazonaphthyridine
TR199902257T2 (tr) Tetrahidropirido bilesikleri
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
PT775118E (pt) Derivados de benzimidazole com actividade dopaminergica
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
WO2001057042A3 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
TR199701605A2 (tr) Sülfonamid-substitüe edilmis bilesikler
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
TR199802200A2 (tr) Sülfonamid sübstitüe edilmis benzopiran türevleri, üretilme yöntemi.
TR199802270A2 (tr) Sülfonamid-ikame etmis anelize 5-halka-bilesikleri.
ID25478A (id) Agonis 5-ht1f
TR199801902A2 (tr) Sülfonamid ile sübstitüe edilmis kromanlar, bunlari içeren farmakolojik bilesimler.
DE60003074D1 (de) Fusidinsäure-derivate